CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | Wolff Stefani EVP and COO | Sale | −342 | $9.88 | $3K | 6,113 |
| 2023-04-30 | Wolff Stefani EVP and COO | Exercise or conversion | +962 | 6,455 | ||
| 2023-04-30 | Wolff Stefani EVP and COO | Exercise or conversion · Restricted Stock Units | −962 | 10,582 | ||
| 2023-02-14 | Wolff Stefani EVP and COO | Grant or award · Employee Stock Option (right to buy) | +88,900 | 88,900 | ||
| 2023-02-14 | Wolff Stefani EVP and COO | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2023-01-30 | Wolff Stefani EVP and COO | Exercise or conversion | +962 | 4,364 | ||
| 2023-01-30 | Wolff Stefani EVP and COO | Sale | −424 | $11.78 | $5K | 3,940 |
| 2023-01-30 | Wolff Stefani EVP and COO | Exercise or conversion · Restricted Stock Units | −962 | 11,544 | ||
| 2022-10-31 | Wolff Stefani EVP and COO | Sale | −350 | $12.88 | $5K | 3,402 |
| 2022-10-30 | Wolff Stefani EVP and COO | Exercise or conversion | +962 | 3,752 | ||
| 2022-10-30 | Wolff Stefani EVP and COO | Exercise or conversion · Restricted Stock Units | −962 | 12,506 | ||
| 2022-08-09 | Wolff Stefani EVP and COO | Grant or award · Employee Stock Option (right to buy) | +110,375 | 110,375 | ||
| 2022-08-01 | Wolff Stefani EVP and COO | Sale | −356 | $15.67 | $6K | 1,238 |
| 2022-07-30 | Wolff Stefani EVP and COO | Exercise or conversion | +962 | 1,594 | ||
| 2022-07-30 | Wolff Stefani EVP and COO | Exercise or conversion · Restricted Stock Units | −962 | 13,468 | ||
| 2022-05-02 | Wolff Stefani EVP and COO | Sale | −330 | $11.75 | $4K | 632 |
| 2022-04-30 | Wolff Stefani EVP and COO | Exercise or conversion | +962 | 962 | ||
| 2022-04-30 | Wolff Stefani EVP and COO | Exercise or conversion · Restricted Stock Units | −962 | 14,430 | ||
| 2022-01-19 | Wolff Stefani EVP and COO | Grant or award · Employee Stock Option (right to buy) | +34,631 | 34,631 | ||
| 2022-01-19 | Wolff Stefani EVP and COO | Grant or award · Restricted Stock Units | +15,392 | 15,392 |
Page 1 of 1 · 20 trades